Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2015
New Zealand Pharmaceutical Schedule - 1 December 2015 update
1 December 2015 - Yet another update to the New Zealand Pharmaceutical Schedule without the listing of a new medicine. ...
Posted by Michael Wonder on 04 Nov 2015
Pharmac hits back at claims Australia has better access to high-cost cancer drugs
3 November 2015 - Pharmac has rebuffed claims New Zealanders have less access to cutting-edge cancer treatments, commissioning research they say ...
Posted by Michael Wonder on 03 Nov 2015
NZers getting access to best cancer medicines says PHARMAC
3 November 2015 - A new analysis of cancer medicine access in Australia and New Zealand shows that New Zealanders are ...
Posted by Michael Wonder on 01 Nov 2015
New Zealand Pharmaceutical Schedule - 1 November 2015 update
1 November 2015 - Another update to the New Zealand Pharmaceutical Schedule without the listing of a new medicine. ...
Posted by Michael Wonder on 29 Oct 2015
PHARMAC proposal to retain first-line biologic access for adalimumab in dermatology and rheumatology indications
29 October 2015 - PHARMAC is seeking feedback on a provisional agreement with AbbVie Limited to reduce the price and subsidy ...
Posted by Michael Wonder on 23 Oct 2015
PHARMAC proposal to list Pheburane (sodium phenylbutyrate)
23 October 2015 - PHARMAC is seeking feedback on a proposal to list sodium phenylbutyrate resulting from a provisional agreement formed ...
Posted by Michael Wonder on 22 Oct 2015
PHARMAC proposal to list Asacol (mesalazine) 800 mg tablets
22 October 2015 - PHARMAC is seeking feedback on a provisional agreement with Baxter Healthcare Limited to list Asacol (mesalazine) 800 ...
Posted by Michael Wonder on 19 Oct 2015
PHARMAC proposals regarding multiple sclerosis treatments
16 October 2015 - PHARMAC is seeking feedback on proposals to list two new treatments for Multiple Sclerosis (MS) – dimethyl ...
Posted by Michael Wonder on 13 Oct 2015
PHARMAC seeks comment on levetiracetam and lamotrigine proposal
13 October 2015 - PHARMAC is seeking feedback on a proposal involving levetiracetam and lamotrigine, resulting from a provisional agreement with ...
Posted by Michael Wonder on 30 Sep 2015
New Zealand Pharmaceutical Schedule - 1 October 2015 update
1 October 2015 - The October 2015 issue of the New Zealand Pharmaceutical Schedule is out and now in effect. There are ...
Posted by Michael Wonder on 30 Sep 2015
PHARMAC - September 2015 tender notification
30 September 2015 - PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some ...
Posted by Michael Wonder on 28 Sep 2015
Request for proposals (RFP) – supply of progestogen-only long-acting intrauterine systems – extension to due date
25 September 2015 - Following consideration of requests, PHARMAC has extended the deadline for responses to the request for proposals (RFP) ...
Posted by Michael Wonder on 18 Sep 2015
Improving access to medicines and devices in primary care in New Zealand
18 September 2015 - To support the health system focus on ‘care closer to home’, PHARMAC is looking at the way ...
Posted by Michael Wonder on 16 Sep 2015
Rare disorders process yields first funding decision
15 September 2015 - People with the rare blood condition hereditary angioedema are the first to benefit from the increased competition ...
Posted by Michael Wonder on 11 Sep 2015
PHARMA decision to list multivitamin for renal patients
11 Seotember 2015 - PHARMAC is pleased to announce the approval of an agreement with Natural Health Laboratories Limited (a subsidiary ...